Translational Development Acquisition Corp.

TDAC | NASDAQ

$10.87

$0 (0.00%)

Sep 22, 2026, 1:15 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	29.79K	438.17K	2.02K	2.23K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	181.66M	174.35M	n/a	n/a
Other Long-Term Assets	n/a	-21.63T	n/a	383.01K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	39.47K	650.23K	2.02K	54.23K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	21.63T	n/a	n/a
Total Long-Term Assets	181.66M	174.35M	n/a	383.01K
Total Assets	181.7M	175M	2.02K	437.24K
Account Payables	162.31K	16.19K	1.25K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	200K	6.11T	347.5K	259K
Other Current Liabilities	n/a	-6.11T	-1.25K	200.34K
Total Current Liabilities	544.07K	210.3K	509.68K	459.39K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.04M	6.04M	n/a	n/a
Total Long-Term Liabilities	6.04M	6.04M	0	-50
Total Liabilities	6.58M	6.25M	509.68K	459.34K
Total Debt	200K	6.11T	347.5K	259K
Book Value	175.12M	168.75M	-507.66K	-22.11K
Book Value Per Share	10.15	41.67	-0.13	-0.01
Common Stock	181.66M	18.33B	466	466
Retained Earnings	-6.54M	-5.6M	-532.66K	-47.11K
Comprehensive Income	n/a	16.88B	n/a	n/a
Shareholders Equity	175.12M	168.75M	-507.66K	-22.11K
Total Investments	181.66M	174.35M	n/a	n/a